Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps.
autoimmunity and allergies
clinical, tolerance
immunology
nanotechnology
Journal
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
08
11
2022
received:
05
09
2022
pubmed:
14
1
2023
medline:
21
3
2023
entrez:
13
1
2023
Statut:
ppublish
Résumé
Autoimmunity and allergies affect a large number of people across the globe. Current approaches to these diseases target cell types and pathways that drive disease, but these approaches are not cures and cannot differentiate between healthy cells and disease-causing cells. New immunotherapies that induce potent and selective antigen-specific tolerance is a transformative goal of emerging treatments for autoimmunity and serious allergies. These approaches offer the potential of halting-or even reversing-disease, without immunosuppressive side effects. However, translating successful induction of tolerance to patients is unsuccessful. Biomaterials offer strategies to direct and maximize immunological mechanisms of tolerance through unique capabilities such as codelivery of small molecules or signaling molecules, controlling signal density in key immune tissues, and targeting. While a growing body of work in this area demonstrates success in preclinical animal models, these therapies are only recently being evaluated in human trials. This review will highlight the most recent advances in the use of materials to achieve antigen-specific tolerance and provide commentary on the current state of the clinical development of these technologies.
Identifiants
pubmed: 36638260
doi: 10.1002/advs.202205105
pmc: PMC10015875
doi:
Substances chimiques
Biocompatible Materials
0
Antigens
0
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2205105Subventions
Organisme : BLRD VA
ID : I01 BX003690
Pays : United States
Organisme : NIH HHS
ID : R01AI169686
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI169686
Pays : United States
Organisme : United States Department of Veterans Affairs
ID : I01BX003690
Organisme : National Institute of Health Training
ID : 5T32AI089621-12
Organisme : NIBIB NIH HHS
ID : R01 EB027143
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI144667
Pays : United States
Organisme : NIH HHS
ID : R01EB027143
Pays : United States
Organisme : NIH HHS
ID : R01AI144667
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI089621
Pays : United States
Informations de copyright
© 2023 The Authors. Advanced Science published by Wiley-VCH GmbH.
Références
Front Immunol. 2020 Oct 22;11:574447
pubmed: 33193362
Biomaterials. 2017 Oct;143:79-92
pubmed: 28772190
Adv Healthc Mater. 2017 Mar;6(6):
pubmed: 28116870
Nat Rev Immunol. 2008 Jul;8(7):523-32
pubmed: 18566595
Front Immunol. 2021 May 27;12:653088
pubmed: 34122410
Immunol Cell Biol. 2022 Jan;100(1):33-48
pubmed: 34668580
Front Immunol. 2022 Mar 14;13:843355
pubmed: 35359943
J Control Release. 2016 Dec 28;244(Pt B):184-193
pubmed: 27369864
Front Physiol. 2021 Oct 11;12:757469
pubmed: 34707514
Nat Rev Mater. 2019 Jun;4(6):429-450
pubmed: 32617176
ACS Biomater Sci Eng. 2021 May 10;7(5):1854-1862
pubmed: 33616392
J Biomed Mater Res A. 2017 Nov;105(11):2977-2985
pubmed: 28646511
Kidney Int. 2001 Jan;59(1):3-16
pubmed: 11135052
Trends Immunol. 2016 Nov;37(11):778-789
pubmed: 27614799
Expert Rev Clin Immunol. 2007 May;3(3):423-36
pubmed: 20477684
Pharmacol Rev. 2013 Aug 01;65(4):1148-61
pubmed: 23908379
Adv Drug Deliv Rev. 2021 Sep;176:113898
pubmed: 34314782
Nat Rev Immunol. 2010 Mar;10(3):170-81
pubmed: 20154735
J Allergy Clin Immunol. 2013 Feb;131(2):412-20
pubmed: 23374268
Nano Lett. 2021 May 12;21(9):3762-3771
pubmed: 33881872
Front Immunol. 2021 May 25;12:637469
pubmed: 34113339
J Intern Med. 2015 Oct;278(4):369-95
pubmed: 26212387
Immune Netw. 2019 Jun 05;19(3):e19
pubmed: 31281716
J Control Release. 2021 Oct 10;338:557-570
pubmed: 34474072
ACS Biomater Sci Eng. 2017 Feb 13;3(2):195-205
pubmed: 28286864
Front Immunol. 2020 Nov 19;11:575451
pubmed: 33329540
Annu Rev Immunol. 2012;30:357-92
pubmed: 22224769
Nature. 2009 Jul 2;460(7251):108-12
pubmed: 19543266
ACS Nano. 2021 Mar 23;15(3):4305-4320
pubmed: 33645967
Nat Commun. 2019 May 14;10(1):2150
pubmed: 31089130
J Immunol. 2021 May 15;206(10):2290-2300
pubmed: 33911007
ACS Biomater Sci Eng. 2019 May 13;5(5):2631-2646
pubmed: 31119191
Nat Rev Immunol. 2001 Nov;1(2):135-45
pubmed: 11905821
Mol Pharm. 2020 Sep 8;17(9):3513-3525
pubmed: 32787283
Nat Rev Immunol. 2011 Nov 11;11(12):823-36
pubmed: 22076556
PLoS One. 2015 Jun 03;10(6):e0127057
pubmed: 26039878
Adv Funct Mater. 2017 Jun 13;27(22):
pubmed: 29503604
Science. 2022 Jan 21;375(6578):296-301
pubmed: 35025605
Nanomedicine. 2017 Jan;13(1):191-200
pubmed: 27720992
Tissue Eng Part A. 2013 Jun;19(11-12):1465-75
pubmed: 23432371
Nat Med. 2000 Oct;6(10):1167-75
pubmed: 11017150
ACS Appl Bio Mater. 2019 Jun 17;2(6):2388-2404
pubmed: 35030696
Bioconjug Chem. 2019 Jul 17;30(7):2049-2059
pubmed: 31274300
Sci Adv. 2020 Oct 16;6(42):
pubmed: 33067238
J Clin Invest. 2015 Jun;125(6):2228-33
pubmed: 25893595
Biomed Rep. 2013 Mar;1(2):177-184
pubmed: 24648915
Exp Neurol. 2015 May;267:254-67
pubmed: 25447934
Diabetes Care. 2011 Jul;34(7):1585-90
pubmed: 21610124
Sci Transl Med. 2021 Mar 10;13(584):
pubmed: 33692135
Diabetes. 2022 Mar 1;71(3):483-496
pubmed: 35007324
ACS Nano. 2021 Jan 26;15(1):1608-1626
pubmed: 33351586
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
Am J Transplant. 2004 Oct;4(10):1614-27
pubmed: 15367216
Immunol Rev. 2010 May;235(1):234-43
pubmed: 20536567
Immunology. 2021 Apr;162(4):452-463
pubmed: 33346377
J Pharm Sci. 2017 Nov;106(11):3293-3302
pubmed: 28625726
Autoimmun Rev. 2003 May;2(3):119-25
pubmed: 12848952
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32017-32028
pubmed: 33239445
Adv Sci (Weinh). 2021 Apr 09;8(10):2003599
pubmed: 34026440
Nature. 2016 Feb 25;530(7591):434-40
pubmed: 26886799
Mol Pharm. 2021 Apr 5;18(4):1806-1818
pubmed: 33734705
Gastroenterology. 2021 Jul;161(1):66-80.e8
pubmed: 33722583
Ther Adv Neurol Disord. 2018 May 10;11:1756286418773025
pubmed: 29774057
Front Immunol. 2017 Dec 11;8:1764
pubmed: 29375543
J Allergy Clin Immunol. 2012 Oct;130(4):918-24.e1
pubmed: 22971521
Immunity. 2015 Apr 21;42(4):607-12
pubmed: 25902480
Front Immunol. 2017 Aug 02;8:909
pubmed: 28824635
J Allergy Clin Immunol. 2019 Dec;144(6):1468-1477
pubmed: 31812181
Polymers (Basel). 2020 Dec 21;12(12):
pubmed: 33371329
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):E60-8
pubmed: 23248266
J Immunol. 2021 Oct 15;207(8):2051-2059
pubmed: 34526376
J Autoimmun. 2018 Sep;93:76-88
pubmed: 30007842
ACS Chem Biol. 2019 Jul 19;14(7):1436-1448
pubmed: 31260253
Front Immunol. 2020 Oct 09;11:529035
pubmed: 33162973
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15745-50
pubmed: 21896725
Nature. 2014 Mar 27;507(7493):519-22
pubmed: 24531764
Front Immunol. 2019 Nov 08;10:2608
pubmed: 31781110
Hum Vaccin Immunother. 2021 Jul 3;17(7):1923-1929
pubmed: 33616474
Biol Sex Differ. 2020 Sep 7;11(1):50
pubmed: 32894183
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):E3432-40
pubmed: 25099355
ACS Chem Biol. 2021 Oct 15;16(10):1985-1993
pubmed: 34037371
Biomater Sci. 2022 Aug 9;10(16):4612-4626
pubmed: 35796247
Front Immunol. 2021 Mar 03;12:555095
pubmed: 33746941
Cell Rep. 2016 Sep 13;16(11):2940-2952
pubmed: 27626664
Front Immunol. 2016 Sep 27;7:382
pubmed: 27729910
Adv Drug Deliv Rev. 2012 Nov;64(14):1547-68
pubmed: 22575858
Ann Am Thorac Soc. 2014 Dec;11 Suppl 5:S306-13
pubmed: 25525738
Nat Immunol. 2011 Apr;12(4):295-303
pubmed: 21358638
Biomaterials. 2019 Jul;210:70-82
pubmed: 31077862
Nat Biomed Eng. 2019 Oct;3(10):817-829
pubmed: 31358881
ACS Nano. 2019 Apr 23;13(4):4778-4794
pubmed: 30964276
BMJ Open. 2019 Jun 28;9(6):e028578
pubmed: 31256036
Biomater Sci. 2019 Feb 26;7(3):798-808
pubmed: 30656310
Nat Med. 2010 Aug;16(8):897-902
pubmed: 20657581
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3329-34
pubmed: 26941238
Annu Rev Immunol. 2018 Apr 26;36:411-433
pubmed: 29677473
ACS Biomater Sci Eng. 2020 Oct 12;6(10):5941-5958
pubmed: 33320581
Int J Pharm. 2019 May 1;562:303-312
pubmed: 30910633
Rheumatol Ther. 2018 Jun;5(1):5-20
pubmed: 29516402
Front Immunol. 2018 Mar 02;9:281
pubmed: 29552007
Nat Commun. 2022 Jun 7;13(1):3279
pubmed: 35672409
Int J Nanomedicine. 2019 Jul 12;14:5229-5242
pubmed: 31371958
Clin Immunol. 2015 Sep;160(1):14-23
pubmed: 25805659
ACS Nano. 2014 Mar 25;8(3):2148-60
pubmed: 24559284
Biomater Sci. 2020 Dec 15;8(24):7014-7032
pubmed: 33179649
J Immunol. 2019 Jul 1;203(1):48-57
pubmed: 31109955
Front Immunol. 2021 Jun 10;12:688460
pubmed: 34177941
JCI Insight. 2019 Sep 19;4(18):
pubmed: 31487265
Front Immunol. 2021 Sep 24;12:714842
pubmed: 34630389
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3157-3162
pubmed: 28270614
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E156-65
pubmed: 25548186
Cells. 2021 Dec 07;10(12):
pubmed: 34943952
Immunity. 2010 Apr 23;32(4):568-80
pubmed: 20381385
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):77-83
pubmed: 31852325
DNA Cell Biol. 2022 Jan;41(1):25-29
pubmed: 34958232
Cell Mol Immunol. 2015 Sep;12(5):553-7
pubmed: 25640656
Sci Transl Med. 2020 Nov 11;12(569):
pubmed: 33177180
J Clin Invest. 2020 Apr 1;130(4):1823-1829
pubmed: 32125290
Adv Sci (Weinh). 2023 Mar;10(8):e2205105
pubmed: 36638260
Allergy. 2019 Feb;74(2):246-260
pubmed: 30035810
J Hepatol. 2015 Jun;62(6):1349-56
pubmed: 25617499
Biomaterials. 2019 Nov;222:119440
pubmed: 31450159
J Control Release. 2020 Jun 10;322:593-601
pubmed: 32087298
Drug Saf. 2014 Nov;37(11):921-43
pubmed: 25270293
Immunol Lett. 2021 Feb;230:49-58
pubmed: 33385440
Mol Pharm. 2019 Apr 1;16(4):1563-1572
pubmed: 30681867
Biomaterials. 2019 Nov;222:119432
pubmed: 31480002
Drug Deliv Transl Res. 2021 Dec;11(6):2468-2481
pubmed: 34611846
Trends Immunol. 2018 Feb;39(2):135-150
pubmed: 29249461
J Autoimmun. 2018 May;89:112-124
pubmed: 29258717
Cold Spring Harb Perspect Biol. 2017 Jun 1;9(6):
pubmed: 28108486
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11270-5
pubmed: 22745170
Sci Transl Med. 2013 Jun 5;5(188):188ra75
pubmed: 23740901
Int J Inflam. 2017;2017:8391230
pubmed: 28553556
Nat Med. 2013 Feb;19(2):139-41
pubmed: 23389609
Med Pharm Rep. 2020 Oct;93(4):342-350
pubmed: 33225259
Mol Ther. 2017 Jul 5;25(7):1676-1685
pubmed: 28408181
Diabetes. 2021 Jun;70(6):1334-1346
pubmed: 33468513
Biomaterials. 2017 Feb;118:51-62
pubmed: 27940382
J Immunol. 2006 Dec 15;177(12):8338-47
pubmed: 17142730
Science. 2021 Jan 8;371(6525):145-153
pubmed: 33414215
Immunol Rev. 2007 Dec;220:199-213
pubmed: 17979848
Mol Ther. 2017 Jul 5;25(7):1655-1664
pubmed: 28479234
Curr Enzym Inhib. 2010 Jul 1;6(2):
pubmed: 24187529
Nat Biotechnol. 2019 Mar;37(3):238-251
pubmed: 30804535
J Control Release. 2021 Mar 10;331:164-175
pubmed: 33450320
Ther Adv Chronic Dis. 2021 Aug 12;12:20406223211037830
pubmed: 34408824
Nanomedicine. 2021 Feb;32:102321
pubmed: 33184020
Proc Natl Acad Sci U S A. 2016 May 3;113(18):5059-64
pubmed: 27091976
ACS Nano. 2016 Oct 25;10(10):9334-9345
pubmed: 27579996
J Immunol. 2020 Apr 1;204(7):1787-1797
pubmed: 32111734
J Control Release. 2020 Feb;318:246-255
pubmed: 31812539
J Clin Invest. 2013 Jul;123(7):3074-83
pubmed: 23722906
Nat Rev Immunol. 2018 Mar;18(3):153-167
pubmed: 28990585
Clin Exp Allergy. 2015 Jan;45(1):21-31
pubmed: 24766371
Vaccine. 2014 Sep 29;32(43):5681-9
pubmed: 25149432
J Allergy Clin Immunol. 2012 May;129(5):1187-97
pubmed: 22464642
J Mol Cell Biol. 2012 Feb;4(1):48-58
pubmed: 22294241
Immune Netw. 2022 Feb 07;22(1):e12
pubmed: 35291653
J Control Release. 2015 Jul 28;210:169-78
pubmed: 26002150
Pharmaceutics. 2021 Nov 17;13(11):
pubmed: 34834364
Nat Nanotechnol. 2022 Mar;17(3):319-330
pubmed: 35039683
Acc Chem Res. 2020 Nov 17;53(11):2534-2545
pubmed: 33074649